Muscarinic and purinergic receptors expressed in keratinocytes are an important part of a functional system for cell growth. While several aspects of this process are clearly dependent on Ca 2 þ homeostasis, less is known about the mechanisms controlling Ca 2 þ entry during epidermal receptor stimulation. We used patch-clamp technique to study responses to carbachol (CCh) and adenosine triphosphate (ATP) in HaCaT human keratinocytes. Both agonists induced large currents mediated by cation-selective channels about three times more permeable to Ca 2 þ than Na þ , suggesting that they play an important role in receptor-operated Ca 2 þ entry. CCh-and ATP-induced currents were inhibited by 1-[6-([(17b)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino)hexyl]-1H-pyrrole-2,5-dione, a phospholipase C (PLC) blocker. Investigation of the pathways downstream of PLC activation revealed that InsP 3 did not affect the agonist responses. In contrast, 1-oleoyl-2-acetyl-sn-glycerol (OAG), a membrane-permeable analog of 1,2-diacylglycerol (DAG), evoked a similar cation current. This action appears to be direct, since the effects of activators or inhibitors of protein kinase C were comparatively small. Finally, transient receptor potential canonical 7 (TRPC7) specific knockdown by antisense oligonucleotides led to a decrease in ATP-and CCh-induced calcium entry, as well as OAG-evoked current. We concluded that activation of both muscarinic and purinergic receptors via a common DAG-dependent link opens Ca 2 þ -permeable TRPC7 channels.
INTRODUCTION
Ca 2 þ -entry pathways are crucial for skin physiology, as they play a pivotal role in several aspects of terminal differentiation, such as cell stratification and cornification. Many studies have shown that inhibition of keratinocyte proliferation and induction of differentiation depend on an increase in intracellular Ca 2 þ concentration ([Ca 2 þ ] i ) due to both Ca 2 þ release and Ca 2 þ entry (Sharpe et al., 1989; Pillai et al., 1990; Pillai and Bikle, 1991; Sharpe et al., 1993; Bikle et al., 1996) , but the mechanisms controlling Ca 2 þ influx in keratinocytes remain largely unknown, particularly regarding epidermal G protein-coupled receptor stimulation. Thus, the keratinocyte plasma membrane is permeable to Ca 2 þ (Sharpe et al., 1989; Pillai and Bikle, 1991; Bikle et al., 1996) and a rise in external Ca 2 þ concentration ('calcium switch') induces increases in [Ca 2 þ ] i and cell differentiation. However, agonist-dependent Ca 2 þ entry pathways have not yet been elucidated.
Several Ca 2 þ -permeable cation channels have been identified in keratinocytes, notably those activated by Ca 2 þ , cyclic guanosine monophosphate, and nicotinic receptors (Mauro et al., 1993; Grando et al., 1996; Oda et al., 1997) . These channels have been implicated in epidermal Ca 2 þ entry mechanisms, while intracellular Ca 2 þ release in keratinocytes has been shown to be evoked by agonists of several receptors coupled to phospholipase C (PLC) activation and InsP 3 formation (Suter et al., 1991; Pillai and Bikle, 1992; Biro et al., 1998; Koizumi and Ohkawara, 1999; Lee et al., 2001) . Store-operated Ca 2 þ entry may also be associated with the Ca 2 þ -releasing action of the PLC-coupled receptor agonists, as it is induced by treating keratinocytes with cyclopiazonic acid, thapsigargin, or phorbol 12-myristate 13-acetate (Jones and Sharpe, 1994a; Csernoch et al., 2000; Gonczi et al., 2002) .
In addition to the putative store-operated Ca 2 þ entry mechanism, there is a possibility that receptor agonists induce Ca 2 þ entry by activating Ca 2 þ -permeable cation channels via other mechanisms. Transient receptor potential (TRP) proteins form cation channels, often characterized by a significant Ca 2 þ permeability, in a number of cell types. In nonexcitable cells, these represent a major route of receptormediated Ca 2 þ entry, either in response to or independently of Ca 2 þ store depletion. In the latter case, 1,2-diacylglycerol (DAG), formed concurrently with InsP 3 by PLC activation, is emerging as an important second messenger that opens certain types of TRP channels (reviewed by Clapham, 2003) .
Thus, in this study, patch-clamp recording techniques and calcium imaging were used to investigate the membrane current responses of HaCaT cells, a spontaneously transformed nontumoral epithelial cell line of human adult skin, to carbachol (CCh) and adenosine triphosphate (ATP). Our main finding is that both receptor agonists induce transitory calcium increases as well as large cation currents with similar biophysical (kinetics, voltage dependence, and ion selectivity) and pharmacological (sensitivity to the blocking action of 2-aminoethoxydiphenyl borate (2-APB), SKF-96365, La 3 þ , and Ni 2 þ ) properties. A cation current with very similar properties was also induced by 1-oleoyl-2-acetyl-snglycerol (OAG), a membrane-permeable analog of DAG, whereas heparin, InsP 3 , or protein kinase C (PKC) activity modulators were ineffective. In the presence of OAG, any additional agonist-induced response was lost, suggesting that DAG formation was the main signal transduction pathway leading to cation channel opening. Reverse transcriptase (RT)-PCR identified transcripts of several transient receptor potential canonical (TRPC) channel proteins (TRPC1, TRPC4, TRPC5, and TRPC7). Moreover, TRPC7 protein downexpression by antisense oligonucleotides inhibited ATP-and CCh-induced calcium entry, as well as OAG-evoked current. Thus, our data demonstrate the existence of receptoroperated Ca 2 þ entry in HaCaT cells, which is at least partially mediated by a DAG-sensitive TRPC7 channel.
RESULTS

Biophysical properties of membrane current responses of HaCaT cells to ATP and CCh
After establishing whole-cell configuration, the cell was held at À40 mV. Voltage ramps of 200 ms duration from À100 to 100 mV were applied at 10 s intervals to monitor the development of the agonist-induced current at different test potentials. At the maximum response, the voltage dependence and kinetics of the current were examined by applying 500-ms-long voltage steps to test potentials ranging from À100 to 80 mV. 
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Application of 100 mM ATP to HaCaT cells induced a transmembrane current, which reversed close to 0 mV ( Figure  1a ) and showed rapid activation and deactivation kinetics on membrane potential step changes ( Figure 1c ). A current with similar reversal potential, amplitude, and kinetics was also activated by applying 20 mM CCh (Figure 1b and c). Low-Cl À pipette and external solutions were used in these experiments, so any contaminating chloride current would be significantly reduced. Consistent with this, both ATP-and CCh-induced currents were insensitive to 5-nitro-2-(3-phenylpropylamino)benzoic acid, a common blocker of many types of chloride channels (data not shown). In contrast, replacing external K þ with N-methyl-D-glucamine (NMDG þ ), a large impermeable cation, virtually abolished the inward current, suggesting that the agonists activated cation-selective channels ( Figure 1d ).
To quantify the relative permeability of several monovalent cations through ATP-and CCh-gated cation channels, we replaced K þ in the divalent cation-free extracellular solution with equimolar amounts of Na þ or Cs þ . Figure 1d shows representative current-voltage (I-V) relationships obtained by applying voltage ramps in the presence of 100 mM ATP ( Figure 1d ) in external solutions containing Na þ , Cs þ , or K þ . Test potentials were corrected off-line for liquid junction potential change as described in Materials and methods. Comparing the shifts in current reversal potential (DE rev ) with the current reversal potential in the presence of 130 mM extracellular Na þ , we obtained the following relative permeability values (n ¼ 5): P K (3.9870.30)4P Cs (2.7970.26)4P Na (1.0) for ATP-induced current and P K (3.5070.25)4P Cs (2.2770.08)4P Na (1.0) for CCh-induced current (not illustrated). There was no statistical difference in the values for the two agonists (P40.1).
We also investigated whether ATP-and CCh-activated cationic channels were permeable to divalent cations, particularly Ca 2 þ . In these experiments, external K þ was replaced with impermeable NMDG þ and 10 mM of various divalent cations tested (Ca 2 þ , Mg 2 þ , and Ba 2 þ ) were added. Representative I-V relationships of ATP-induced current responses, measured by applying voltage ramps in the presence of different divalent cations, are shown in Figure 1d , right panel. Using equation (2) P X /P Cs , permeability ratios were obtained for different divalent cations (X) and the following relative divalent cation permeability profiles were calculated from these values (n ¼ 4): P Ca (1.0)4P Mg (0.7570.06)4P Ba (0.4270.04) for ATP-induced current and P Ca (1.0)4P Mg (0.7870.07)4P Ba (0.4670.02) for CCh-induced current. Thus, divalent cation permeability profiles were also the same for both ATP-and CCh-induced currents (P40.4).
As relative Na þ and Ca 2 þ permeability through the channel is most relevant from a physiological standpoint, we also estimated the P Ca /P Na ratio based on the E rev shift following replacement of NMDG þ -based solution containing 10 mM Ca 2 þ with a 130 Na þ , divalent cation-free solution. These experiments gave the following permeability ratio (n ¼ 5): P Ca /P Na ¼ 2.7770.65 for ATP-induced current. The permeability ratio P Ca /P Na for CCh-induced currents did not differ significantly (P Ca /P Na ¼ 2.4070.75; P40.7).
These results show that both ATP and CCh-induced cation-selective currents in HaCaT cells have similar biophysical properties. Thus, it is likely that both agonists target the same Ca 2 þ -permeable cation channel. To further explore this hypothesis, we next examined the pharmacological properties of ATP-and CCh-induced currents.
Pharmacological properties of membrane current responses of HaCaT cells to ATP and CCh
We examined the effects of several ion-channel blockers: 2-APB, an inhibitor of some store-operated and TRP channel proteins (Braun et al., 2001; Diver et al., 2001) , and SKF-96365, a common blocker of receptor-operated Ca 2 þ entry in nonexcitable cells (Merritt et al., 1990) , as well as La 3 þ and Ni 2 þ , inorganic blockers of various cation channels.
2-APB at 100 mM significantly inhibited ATP-induced cationic current in HaCaT cells, that is, by 6074% (n ¼ 5). This block developed rapidly and was completely reversible (Figure 2a ). SKF-96365 (25 mM) inhibited ATP-induced current by 3273% (Figure 2a and b; n ¼ 8). Similar results were obtained for CCh-evoked cation current (5873 and 2974% for 100 mM 2-APB and 25 mM SKF-96365, respectively, n ¼ 6; data not shown). The values were similar for both ATP-and CCh-induced currents (P40.5).
Ni 2 þ (100 mM) had no significant effect on either ATPinduced current (Figure 2b , n ¼ 4) or CCh-induced current (data not shown). La 3 þ was tested in the concentration range from 1 mM to 2 mM. Fitting the inhibition curve by the Hill equation yielded the IC 50 value for the blocking action of La 3 þ on ATP-induced current of 8676 mM, with a slope factor in the vicinity of 1 (not illustrated). Figure 2b summarizes our findings for the inhibitory action of several common cation channel blockers on the current response evoked in HaCaT cells by 100 mM ATP.
Signal transduction pathways involved in cation current generation in response to ATP and CCh
Several subtypes of P2Y purinergic (e.g., P2Y1 and P2Y2) and muscarinic (M 1 -M 5 ) receptors are expressed in human epidermal keratinocytes at high densities (Grando et al., 1995; Ndoye et al., 1998; Arredondo et al., 2003; Greig et al., 2003a, b; Chernyavsky et al., 2004) . We used several receptor-specific pharmacological tools to identify the receptor type involved in the ATP-and CCh-induced responses. Thus, we investigated the sensitivity of CChevoked Ca 2 þ entry to atropine -a high-affinity muscarinic receptor antagonist. Under control conditions, CCh induced a transitory calcium entry (Figure 2c ), which was strongly inhibited when atropine was added to the medium (50 mM). This result points to a major involvement of muscarinic receptors in the CCh-induced calcium response. The ATPinduced calcium response was inhibited by suramin (100 mM), a well-known P2Y receptor antagonist (Lee et al., 2001) , thus suggesting that P2Y purinergic receptors were involved. Figure 2d summarizes the results showing the inhibitory action of atropine and suramin on the calcium responses evoked in keratinocytes by CCh and ATP (n ¼ 98 and n ¼ 101), respectively.
Purinergic and odd-numbered muscarinic receptors are commonly coupled to PLC stimulation, resulting in the formation of InsP 3 and intracellular Ca 2 þ store release. The Ca 2 þ -releasing effect of several receptor agonists is well documented in keratinocytes (Suter et al., 1991; Pillai and Bikle, 1992; Biro et al., 1998; Koizumi and Ohkawara, 1999; Csernoch et al., 2000; Koegel and Alzheimer, 2001; Lee et al., 2001) . There is also evidence that this effect in keratinocytes is mediated by the common pathway linking receptor activation to phosphoinositide metabolism stimulation (Pillai and Bikle, 1992) , an effect shown to be inhibited by 1-[6-([(17b)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino)hexyl]-1H-pyrrole-2,5-dione (U-73122), a PLC blocker (Lee et al., 2001) .
In order to reveal the dependence of the agonist-evoked cation current in HaCaT cells on the signaling cascade triggered by PLC-catalyzed phosphoinositide turnover, we used U-73122, while its inactive analog 1-[6-([(17b)-3methoxyestra-1,3,5(10)-trien-17-yl]amino)hexyl]-2,5-pyrrolidinedione (U-73343) was used in control experiments. U-73122 (10 mM) nearly completely blocked ATP-evoked cationic current (Figure 3a) , whereas U-73343 had no effect (not illustrated). In the same manner, we investigated the action of U-73122 and U-73343 on ATP-and CCh-evoked Ca 2 þ entry. Thus, U-73122 strongly inhibited both agonist Ca 2 þ responses (86.774.7 and 75.775.8 inhibition, respec-tively), while U-73343 had no significant action. These results are summarized in Figure 3b . We further addressed the possibility that InsP 3 could be a second messenger mediating channel opening either by direct interaction or via Ca 2 þ store depletion. Thus, in the next series of experiments, agonists were applied to cells dialyzed with 100 mM InsP 3 . Cell dialysis with InsP 3 did not evoke any significant cation current by itself, nor did it affect the time course or maximum amplitude of the subsequent response to ATP (Figure 3c ). Cell dialysis with heparin (1 mg/ml), an InsP 3 receptor blocker, had no effect on cation current responses to ATP or CCh either (not illustrated). These results imply that agonistinduced cation current develops independently of Ca 2 þ store depletion, or at least irrespectively of InsP 3 production. It also made it very unlikely that the above-described inhibitory effect of 2-APB was related to InsP 3 receptor blockade.
DAG is another important intracellular messenger, formed concurrently with InsP 3 during PLC activation. There is accumulating evidence that DAG can activate cation channels formed by certain TRP proteins by itself (Hofmann et al., 1999; Gudermann et al., 2004) and that simultaneous activation of PKC may also play an important role in DAGmediated channel regulation (Venkatachalam et al., 2004) . Thus, we hypothesized that DAG was the second messenger involved in generating the agonist-evoked cation current in 
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HaCaT cells, possibly via the modulation of PKC activity. To test this hypothesis, we used OAG, a membrane-permeable DAG analog. Application of 100 mM OAG to HaCaT cells following ATP application produced an additional cationic current (Figure 3d ; n ¼ 10). Notably, coapplication of ATP or CCh during maximum OAG-induced response failed to activate any additional current (Figure 3d and e). The lack of additive action of OAG and ATP suggests that they converge on a common signal transduction pathway. Similar results were obtained for CCh-induced currents, suggesting that both agonists commonly activate cation channels via PLC-dependent DAG production. As DAG is known to activate PKC, we also examined whether PKC activation contributed to the effect of ATP and CCh on cation current generation in HaCaT cells. phorbol 12-myristate 13-acetate (100 mM), a membrane-permeable PKC activator, evoked an inward current that was significantly potentiated following ATP application (Figure 4a ; n ¼ 4). Furthermore, OAG-induced current was only slightly inhibited by 500 nM bisindolylmaleimide, a PKC inhibitor ( Figure 4b ; n ¼ 4), but was insensitive to 1 mM staurosporine ( Figure 4c ; n ¼ 6). These results imply that PKC activation plays only a minor role in the cation current responses of HaCaT cells to ATP and CCh. These responses therefore seem to be largely mediated by DAG alone.
RT-PCR analysis
The results described above prompted us to investigate whether certain types of TRP channels were present in human keratinocytes, particularly those of the classical (short) TRPC family, which share a common PLC-dependent activation mechanism (Hofmann et al., 1999; Clapham, 2003; Gudermann et al., 2004; Venkatachalam et al., 2004) . While some members of this family are believed to open as a result of Ca 2 þ store depletion, there is growing evidence that others may be gated by lipid messengers. Notably, TRPC3, C6, and C7 form a structurally and functionally related subfamily of DAG-sensitive channel proteins. As a first step in studying the molecular identity of the channels mediating agonist-induced cation current in HaCaT cells, we studied the expression of the mRNA of the several human TRPC isoforms (TRPC1, TRPC3, TRPC4, TRPC5, TRPC6, and TRPC7) using specific primers (Table 1 ) and the RT-PCR technique. For TRPC1, TRPC4, and TRPC6, the primers (Table 1) surrounded the mRNA regions subjected to an alternative splicing generating the isoforms for these TRPC subtypes. Figure 5 shows the expression of the TRPC transcripts in HaCaT cells. PCR products of the expected sizes for TRPC1A (Figure 5a ), TRPC4 (Figure 5c ), TRPC5 (Figure 5d ), and TRPC7 (Figure 5f ) were found in these cells.
These results suggest that TRPC1A, C4 (unspliced form), C5, and C7 mRNAs are present in HaCaT cells, while TRPC3 and C6 mRNAs were undetectable.
Candidate for DAG-activated current
It is now well established that several TRP channels can be activated directly by DAG. Among the TRPC subfamily, TRPC3, TRPC6, and TRPC7 have already been described as 
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DAG-dependent receptor-operated channels (Gudermann et al., 2004) . Given our results on TRPC channel expression, TRPC7 appeared to be the sole candidate for the DAGactivated channel in our model. We therefore used the antisense oligonucleotide strategy to study the impact of specific TRPC7 down-expression on ATP-and CCh-evoked Ca 2 þ increases, as well as OAG-evoked currrent. This treatment inhibited TRPC7 translation by 73%, without Figure 6) . So, we observed that TRPC7 down-expression resulted in a smaller increase in cytoplasmic Ca 2 þ following purinergic receptor activation by ATP (Figure 7a) . A 2-day TRPC7 antisense oligonucleotide treatment inhibited ATP-activated Ca 2 þ response by 47.876.7% (n ¼ 105) and CCh-evoked response by 50.8710.6% (n ¼ 101). The results of TRPC7 protein downexpression on ATP-and CCh-evoked calcium responses are summarized in Figure 7b . Furthermore, we studied the consequence of TRPC7 down-expression on OAG-evoked current to check the pivotal role of DAG in TRPC7 gating. So, we observed that TRPC7 down-expression resulted in a smaller OAG activated current (Figure 7c) . A 2-day TRPC7 antisense oligonucleotide treatment inhibited OAG-evoked current by 45.874% (Figure 7d ), demonstrating the specific activation of this channel by DAG produced downstream of PLC activation.
DISCUSSION
In this study, we showed for the first time that stimulation of purinergic and muscarinic receptors in HaCaT human keratinocytes resulted in the generation of sustained cation currents with similar biophysical and pharmacological properties. Cation channels mediating this current are about three times more permeable to Ca 2 þ than Na þ . These data imply that, under physiological conditions, agonist-induced cation current can mediate substantial Ca 2 þ influx, thus contributing to a further intracellular Ca 2 þ increase in addition to that produced by the well-established PLCmediated Ca 2 þ -release (Suter et al., 1991; Pillai and Bikle, 1992; Biro et al., 1998; Koizumi and Ohkawara, 1999; Csernoch et al., 2000; Koegel and Alzheimer, 2001; Lee et al., 2001) . Indeed, in HaCaT cells [Ca 2 þ ] i signals during phosphoinositide agonist action are biphasic: the initial transient [Ca 2 þ ] i increase is brought about by InsP 3 -induced Ca 2 þ release insensitive to external Ca 2 þ , but the second, more sustained, phase depends critically on Ca 2 þ influx. The second phase was previously attributed to store-operated Ca 2 þ entry (Jones and Sharpe, 1994a; Csernoch et al., 2000) , although we have demonstrated the existence of an additional agonist-activated InsP 3 -independent Ca 2 þ entry pathway in keratinocytes. It has long been known that, in keratinocytes, an increase in external Ca 2 þ induces differentiation associated with a sustained increase in [Ca 2 þ ] i due to Ca 2 þ entry, even in the absence of receptor stimulation. However, this Ca 2 þ entry is sensitive to the blocking action of Ni 2 þ (Jones and Sharpe, 1994b) . In contrast, the agonist-induced cation current described here was Ni 2 þ -insensitive (Figure 2b) , indicating that passive and receptor-dependent Ca 2 þ entries are mediated by different channels.
In general, the functional role of the purinergic system in keratinocytes, including ATP-dependent changes in Ca 2 þ homeostasis, has been studied more extensively than that of the cholinergic system. It has, however, been known for about a decade that human keratinocytes possess cholinergic enzymes for acetylcholine synthesis and degradation (Grando et al., 1993) and the more recently demonstrated uptake of choline by CHT1, a high-affinity choline transporter, at choline acetyltransferase sites, is expected to promote acetylcholine synthesis (Pfeil et al., 2003) . Human keratinocytes are also responsive to acetylcholine, believed to act as a local hormone in the epidermis (Grando et al., 1993; Grando, 1997) .
Several important functions have been attributed to muscarinic cholinergic receptors in keratinocytes, including control of cell viability, proliferation, adhesion, migration, and differentiation (Grando, 1997; Ndoye et al., 1998; Arredondo et al., 2003; Chernyavsky et al., 2004) . Also, the pattern of muscarinic receptor subtypes expressed in keratinocytes changes completely at each stage in their development, suggesting that each receptor subtype may regulate a specific cell function. Moreover, under pathological conditions, tissue levels of acetylcholine in skin biopsies are greatly increased (Wessler et al., 2003) .
Further studies are needed to establish the precise mechanisms of acetylcholine action on keratinocytes. It is assumed that acetylcholine acts via calcium, which acts as a mediator of its effects in the epidermis (Grando, 1997 ); yet, the Ca 2 þ -releasing effect of CCh appears to be weak compared to other agonists such as bradykinin, histamine, or ATP (Biro et al., 1998) . Thus, these results substantially extend our knowledge of Ca 2 þ metabolism regulation mechanisms in keratinocytes during the action of acetylcholine by demonstrating a novel DAG-dependent Ca 2 þ entry pathway triggered by muscarinic receptor stimulation. M 1 , M 3 , or M 5 receptors are apparently involved in this effect, as these are commonly linked to the enhanced PLC-mediated phospholipid turnover in other cell types (reviewed by Caulfield and Birdsall, 1998) and these receptor subtypes are present in epidermal keratinocytes (Ndoye et al., 1998; Arredondo et al., 2003) . It has not yet been established whether all odd-numbered muscarinic receptor subtypes are involved, or one specific subtype predominates in cation current generation in keratinocytes.
P2Y1 and P2Y2 purinergic receptors are also expressed in keratinocytes at high density and are believed to be part of a functional signaling system controlling cell proliferation (Greig et al., 2003a, b) . In the epidermis, ATP is released from platelets during wound healing, potentially exposing keratinocytes to agonist concentrations sufficient to stimulate phosphoinositide turnover and evoke InsP 3 -induced Ca 2 þ release. Although a rise in [Ca 2 þ ] i during ATP action is well documented in keratinocytes (Suter et al., 1991; Pillai and Bikle, 1992; Lee et al., 2001) , the possibility of Ca 2 þ entry in addition to Ca 2 þ release triggered by purinergic receptor stimulation has not yet been addressed. Our current results strongly imply that there is an ATP-mediated Ca 2 þ entry pathway of this type in keratinocytes. Moreover, it shares the main biophysical and pharmacological characteristics with the pathway activated by muscarinic receptor stimulation. We used calcium-imaging experiments and pharmacological tools such as atropine and suramin to investigate the type of receptors related to ATP-and CCh-evoked calcium response. Our findings highlighted the involvement of P2Y purinergic and M1 muscarinic receptors in ATP-and CCh-induced calcium entry, respectively. Furthermore, our experiment using U73122, a specific PLC inhibitor, confirmed this first observation, indicating that both types of receptors are coupled to PLC pathways and, consequently, to IP 3 and DAG synthesis.
Further experiments designed to investigate the underlying signal transduction pathways showed that the similarities between cation currents induced by CCh and ATP extended to the common involvement of PLC activation and downstream effects of DAG, but not InsP 3 or PKC activation (Figures 3 and 4) . These results imply that the same Ca 2 þpermeable cation channel is targeted by both agonists and, presumably, other receptor agonists stimulating phosphoinositide turnover in keratinocytes may be capable of opening this channel.
We hypothesized that DAG-sensitive members of the novel TRP channel protein family may form the cation channel activated by phosphoinositide agonists in HaCaT keratinocytes. Our RT-PCR analysis showed that mRNAs encoding TRPC1, C4, C5, and C7 were present in HaCaT cells, while TRPC3 and C6 transcripts were undetectable. This pattern of TRPC channel expression was different from the one described in primary cultured keratinocytes (Cai et al., 2005; Tu et al., 2005) . This result highlights a certain difference between the phenotype of HaCaT cell line and primary cultures in spite of the ability of HaCaT to undergo differentiation ''in vitro'' and ''in vivo'' like normal keratinocytes. As TRPC3, C6, and C7 form a structurally and functionally related subfamily of channel proteins sensitive to DAG (Hofmann et al., 1999; Gudermann et al., 2004; reviewed by Clapham, 2003) , TRPC7 may be involved in ATP-and CCh-induced current generation in HaCaT cells.
Furthermore, TRPC7 specific downexpression by antisense oligonucleotide strategy inhibited both ATP-and CChactivated calcium entry, as well as OAG-evoked current (Figure 7) , pointing to a DAG-dependent activation of TRPC7 in HaCaT cells. A recent study has broadly explored the way of TRPC7 activation and demonstrated that, depending on the conditions of TRPC7 overexpression, this channel could be activated like store-operated channels (SOC) channel or like receptor-operated channels (Lievremont et al., 2004) . The same group demonstrated that TRPC7 acts like a DAGdependent channel when endogenously expressed in B-cells (Lievremont et al., 2005) . Our results on selective TRPC7 knockdown clearly indicate the involvement of this protein in OAG-activated current in human keratinocytes (Figure 7) , although a significant residual component insensitive to antisense treatment may indicate either incomplete TRPC7 downregulation, as indicated by RT-PCR results (Figure 6 ), or the involvement of other channel proteins. Among the TRPC channels expressed in primary cultured keratinocytes, some are known to be structurally very close to TRPC7. So, in primary cultures, TRPC3 and TRPC6 might be gated in the same manner as TRPC7 in HaCaT. The same situation has been observed in prostate cancer epithelial cells; indeed, while in prostatic cell line, the so-called lymph node carcinoma of the prostate, DAG-activated current is carried by TRPC3, the analog current in primary culture is carried by TRPC6, which is structurally very close to TRPC3 .
The Ca 2 þ permeability of TRPC7 relative to Na þ is about one order of magnitude lower (Clapham, 2003) than that in HaCaT cells, raising the possibility that other TRP proteins may coassemble to form DAG-sensitive cation channels in keratinocytes. Interestingly, TRPC1, which appears to be a store-operated channel when it is expressed in mammalian cells, is insensitive to Ca 2 þ store depletion when expressed in Sf9 cells and shows similarities to the cation current in HaCaT cells: voltage dependence, Ca 2 þ selectivity, and sensitivity to La 3 þ (Sinkins et al., 1998) . Also, heteromers TRPC1/C5 as well as TRPC1/C3 are cation channels activated by Gq/PLC-coupled receptors (Strubing et al., 2001) and DAG (Lintschinger et al., 2000) , respectively, but not by of Ca 2 þ -store depletion.
In conclusion, this study presents a novel example of a DAG-sensitive, PKC-and Ca 2 þ store-insensitive cation current present in human keratinocytes. The voltage dependence, pharmacological properties, and gating mechanisms of this current appear to be very similar to the growing list of its counterparts in other cell types (Helliwell and Large, 1997; Tesfai et al., 2001; Jung et al., 2002; Lee et al., 2003; Sydorenko et al., 2003; Thebault et al., 2003; Trebak et al., 2003) .
MATERIALS AND METHODS
Cell culture
HaCaT keratinocytes (kindly provided by CNRS UNR 5543, Bordeaux) were cultured in (DMEM; Gibko, Paisley, UK) supplemented with 10% fetal bovine serum (Seromed, Poly-Labo, Strasbourg, France). The culture medium contained 0.5 mM CaCl 2 and 10 mg/l kanamycine. Cells were grown in 50 ml flasks (Poly-Labo) and kept at 371C in a humidified incubator in an air/CO 2 (95/ 5%) atmosphere. For electrophysiology experiments, the cells were subcultured in Petri dishes (Nunc, France) and used within 3-6 days. For electrophysiological recordings, the cells were separated by a brief trypsin treatment (0.1%, 5-7 min) 1 hour before the experiment.
Reverse transcription-PCR analysis
Total RNA from HaCaT cells was isolated by the guanidium thiocyanate-phenol-chloroform extraction procedure. After a deoxyribonuclease I treatment (0.1 U/ml, 1 hour at 251C; Life Technologies, Inc., Rockville, MD) to eliminate genomic DNA, total RNA was reverse transcribed into cDNA as described by Roudbaraki et al. (1999) . Table 1 shows the specific sense and antisense primers used for the PCR reaction, based on GenBank human TRP (hTRP) sequences and designed using Genejockey II (Biosoft, Cambridge, UK). Primers were synthesized by Invitrogen, Paisley, UK. 
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Each sample was amplified by Ampli-Taq Gold DNA Polymerase (Perkin-Elmer, Foster City, CA) in an automated thermal cycler (GenAmp 2400, Perkin-Elmer). DNA amplification conditions included an initial 7-minutes denaturation step at 951C (which also activated the Taq Gold) and 40 cycles of 30 seconds at 951C, 30 seconds at 581C, 40 seconds -1 minute (depending on the fragments amplified) at 721C with a final elongation of 7 minutes at 721C. The PCR products were subjected to electrophoresis on a 1.5-2% agarose gel and stained with ethidium bromide (0.5 mg/ml), then visualized under UV. For identification, each PCR band was extracted from the gel, then subjected either to restriction analysis using the specific enzymes for each amplified fragment or subcloned in TA-cloning vector (Invitrogen) followed by sequencing analysis.
Antisense assays
For antisense assays, the sense (control) and antisense oligonucleotides (Eurogentec, Seraing, Belgium) targeted at TRPC7 were designed at the initiating ATG codon level (see Table 1 for sequences). The HaCaT cells were treated for up to 72 hours with 0.5 mM phosphorothioate antisense or sense oligodeoxynucleotides by adding them directly to the culture medium. The oligodeoxynucleotides were transfected using Geneporter-2 (Ozyme) in 2 ml serum-free DMEM-HG.
Patch-clamp recordings
Membrane currents were recorded at room temperature using an Axopatch 200B patch-clamp amplifier (Axon Instruments Inc., Foster City, CA). Low-Cl À extracellular and intracellular solutions were used to minimize chloride currents (Galietta et al., 1991; Koegel and Alzheimer, 2001) . The basic extracellular solution contained (in mM): 130 K-glutamate, 0.5 CaCl 2 , 1 MgCl 2 , 10 glucose, 10 HEPES, and 10 TEAOH, pH adjusted to 7.3 using glutamic acid. Patch pipettes made of borosilicate glass (resistance 3-5 MO) were filled with the following solution (in mM): 130 cesium methanesulfonate, 1 MgCl 2 (calculated free Mg 2 þ concentration: 0.21 mM), 2.5 CaCl 2 (calculated free Ca 2 þ concentration: 150 nM), 10 HEPES, 4 EGTA, 1 Na 2 ATP, 0.1 Na 3 GTP, pH adjusted to 7.3 with glutamic acid (osmolality: 305 mosmol/l). Capacitance and series resistance (70-80% compensation) but not leak current were compensated on-line. Current recordings were filtered at 5 kHz and acquired using a Digidata 1200 interface and pClamp software (Axon Instruments Inc., Foster City, CA).
To measure currents carried by various monovalent cations, external K þ was replaced with equimolar quantities of Na þ , Cs þ , or NMDG þ . We estimated the permeability of different monovalent cations through CCh-or ATP-activated channels from the shift of the reversal potential for K þ or Cs þ currents relative to Na þ current, DE rev , and calculated respective permeability ratios using the following equation:
where F, R, and T have their usual meanings. Appropriate liquid junction potential corrections were applied to the reversal potential measurements off-line. The values calculated using the pClamp software were as follows: À2 mV for K þ -, 4.1 mV for Na þ -, and À2.9 mV for Cs þ -based external solution.
Divalent cation permeability was measured in solutions containing 10 mM CaCl 2 , BaCl 2 , or MgCl 2 , and 120 mM NMDG þ instead of K-glutamate. Divalent cation permeability ratios were calculated from the current reversal potential measured in an external solution containing a divalent cation (E X ), first relative to P Cs (equation (2) below), then by comparing P X /P Cs values for different divalent cations (X):
where [Cs þ ] i is the internal cesium concentration and [X] o is the external divalent cation X concentration. The permeability ratio of Ca 2 þ relative to Na þ was estimated from the shift of the reversal potential (E Ca ÀE Na in eq. 3 below) in solutions containing 130 mM Na þ (Ca 2 þ -free) or 10 mM Ca 2 þ (Na þfree, NMDG þ substituted) (Kamouchi et al., 1999) :
where E Ca and E Na are current reversal potentials measured with [Ca] o ¼ 10 mM and [Na] o ¼ 130 mM, respectively. Osmotic differences were compensated by adding mannitol in order to adjust the osmolality of all external solutions to 315 mosmol/l. The E X values were corrected for liquid junction potential changes, calculated as described above: 11.8 mV for high-Ca 2 þ , 12.1 mV for high-Mg 2 þ , and 11.7 mV for high-Ba 2 þ external solution. External solutions were changed using a multi-barrel puffing micropipette with a common outflow positioned in close proximity to the cell under investigation. During the experiment, the cell was continuously superfused with the solution via the puffing pipette to reduce possible artifacts related to the switches from static to moving solution and vice versa. The external solution was replaced in less than 1 second.
